Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.

Higano, Celestia S

Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone. [electronic resource] - Clinical genitourinary cancer Mar 2008 - 40-5 p. digital

Publication Type: Journal Article

1558-7673

10.3816/CGC.2008.n.007 doi


Adenocarcinoma--drug therapy
Aged
Aged, 80 and over
Analgesics, Non-Narcotic--administration & dosage
Bone Neoplasms--drug therapy
Dose-Response Relationship, Drug
Feasibility Studies
Humans
Male
Middle Aged
Neoplasms, Hormone-Dependent--pathology
Organometallic Compounds--administration & dosage
Organophosphorus Compounds--administration & dosage
Prostatic Neoplasms--pathology
Samarium
Survival Rate